AstraZeneca expands investment in Qingdao
1 year, 3 months ago

AstraZeneca expands investment in Qingdao

China Daily  

Visitors check out the exhibition area of AstraZeneca during the 2022 China International Import Expo in Shanghai on Nov 5. TANG YANJUN/CHINA NEWS SERVICE United Kingdom-based pharmaceutical company AstraZeneca, a Fortune Global 500 company, signed a cooperation agreement with the Qingdao National High-tech Industrial Development Zone on Aug 14 to further expand its Breztri Aerosphere inhalation aerosol production and supply project. So far, it has invested $1.5 billion into research and development, while China has developed into AstraZeneca's second largest market. According to senior industry insiders, China is expected to become the world's largest medical market and an important global source for medical technology innovation. As the main carrier of the city's biomedicine and medical device industries, the Qingdao High-tech Zone is focusing on cultivating a large health industrial cluster that has international influence and strong competitiveness.

China Qingdao Astrazeneca  expands  china  qingdao  market  strong  signed  agreement  industrial  medical  zone  astrazeneca  investment

History of this topic

AstraZeneca announces plans for new innovations for China
2 months, 3 weeks ago

AstraZeneca announces plans for new innovations for China

China Daily  

Sharon Barr, executive vice-president of biopharmaceuticals R&D at AstraZeneca, delivers a speech at AstraZeneca R&D China Science Day held in Shanghai from Friday to Saturday. Announcing Shanghai as a global strategic site for the company in February, AstraZeneca currently has over 200 projects in its R&D pipeline in China, which plays an important part in the company's overall blueprint of …

AstraZeneca staff detained in China amid claims of illegal drug imports
3 months, 2 weeks ago

AstraZeneca staff detained in China amid claims of illegal drug imports

The Telegraph  

Five AstraZeneca staff have been detained in China amid claims of potential illegal activity at the British drug giant. Authorities in Shenzhen, China, are investigating how the company collected patient data, according to Bloomberg, as well as investigating the imports of a liver cancer drug yet to be approved in China. A spokesman for AstraZeneca said: “We are aware a …

Foreign firms expand investment in nation
3 months, 3 weeks ago

Foreign firms expand investment in nation

China Daily  

Despite global foreign direct investment exhibiting a contraction trend in 2023 due to factors such as sluggish economic growth and geopolitical tensions, China's inbound investment flow remained relatively high in the past decade, said a report released on Aug 28. In the first half of 2024, multinational companies continued to increase their investment in China and optimize their industrial strategies, …

Foreign firms expand investment in nation
3 months, 3 weeks ago

Foreign firms expand investment in nation

China Daily  

A view of the booth of Zeiss Group during an expo in Shanghai. Despite global foreign direct investment exhibiting a contraction trend in 2023 due to factors such as sluggish economic growth and geopolitical tensions, China's inbound investment flow remained relatively high in the past decade, said a report released on Wednesday. In the first half of 2024, multinational companies …

Annual big event brings huge opportunities to Qingdao
3 months, 4 weeks ago

Annual big event brings huge opportunities to Qingdao

China Daily  

The 5th Qingdao Multinationals Summit is held from Aug 27 to 29. The 5th Qingdao Multinationals Summit in Qingdao, Shandong province is being held from Aug 27 to 29. Qingdao, along with Shandong, leverages its unique geographical advantages, robust scientific and technological capabilities, and open investment environment to create favorable conditions for the rapid growth of the health industry," said …

Med-tech of China gaining popularity
7 months, 1 week ago

Med-tech of China gaining popularity

China Daily  

AstraZeneca, a United Kingdom-headquartered pharmaceutical company, showcases its cutting-edge products and solutions at the sixth China International Import Expo. While taking strides to go global, China's medical technology sector has shown signs of overtaking and leading the world in some fields, such as cell therapy, gene editing, various medical equipment and certain cancer treatments, said a senior executive of a …

Multinational pharmaceutical company commences project in Qingdao
9 months, 3 weeks ago

Multinational pharmaceutical company commences project in Qingdao

China Daily  

The AstraZeneca inhalation aerosol production and supply base located in Qingdao National High-tech Industrial Development Zone recently began construction, with over 30 workers operating four pile drivers. It will primarily engage in the production and assembly of inhalation aerosol products, including medications for respiratory diseases. The base represents a breakthrough in the construction of manufacturing projects by multinational pharmaceutical companies …

AstraZeneca returning for sixth successive expo
1 year, 1 month ago

AstraZeneca returning for sixth successive expo

China Daily  

AstraZeneca, a United Kingdom-headquartered pharmaceutical company, showcases its cutting-edge products and solutions at the sixth China International Import Expo. CHINA DAILY By participating in the China International Import Expo for the sixth successive year with cutting-edge healthcare products and solutions, AstraZeneca, a United Kingdom-headquartered global pharmaceutical company, is underlining its unwavering commitment to the Chinese market. During the expo, the …

AstraZeneca plots to sell AI drug unit to the Chinese
1 year, 6 months ago

AstraZeneca plots to sell AI drug unit to the Chinese

The Telegraph  

AstraZeneca’s pioneering artificial intelligence research centre could fall into foreign ownership under reported plans for the drugs giant to spin off and separately list its Chinese division. The Chinese division owns the company’s global research and development centre in Shanghai, as well as an “AI innovation centre” being developed there. There is a lot of investment, a lot of new …

7 AstraZeneca projects to settle in Qingdao
2 years, 1 month ago

7 AstraZeneca projects to settle in Qingdao

China Daily  

AstraZeneca, the world's leading biopharmaceutical company, has further deepened cooperation with Qingdao after signing seven key projects during the fifth China International Import Expo in Shanghai. The projects include the AstraZeneca Inhalation Aerosol Factory, the AstraZeneca Pharma Co, the Qingdao International Life Science Innovation Park, the Qingdao Smart Medical Innovation Center, and the Health Industry Fund. Wang Lei, global executive …

Discover Related